ArticleChemistryOpen2026

Design, Synthesis, Cytotoxicity Assessment, and Molecular Docking of Novel Triazolopyrimidines as Potent Cyclin-Dependent Kinase 4 Inhibitors.

Tariq Z Abolibda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.